The Chinese government has published draft regulations interpreting the country’s antitrust law which contains language that IP owners say is worryingly vague
US pharmaceutical company Pfizer has sold the Chinese IP rights for a swine flu vaccine to a domestic company to comply with an anti-monopoly review by the Chinese Ministry of Commerce
China's long-awaited Anti-Monopoly law comes into effect on August 1, but its impact on IP owners is far from certain, explain Kirstie Nicholson and Zirou Liu
China’s Anti-Monopoly Law will be enforced by three government agencies, according to official news sources
Read this year's INTA Daily News - published daily by Managing IP direct from the 134th INTA Annual Meeting in Washington DC